Director Shoji Koga

My career as a physician began in 1989 when I started as a clinical doctor.

I had the opportunity to engage in basic research for three years as a research fellow at the Cleveland Clinic in the United States from 1996 to 1999. During that time, I was immersed in research from morning till night.

Since returning to the university in 1999, I have honed my skills as a clinical doctor, handling numerous cases such as kidney transplants and more recently, robotic surgeries.

In 2016, I had the opportunity to work in regenerative medicine using stem cell culture supernatant in private medical services at Ginza Solaria Clinic. Over the next five years, I focused mainly on research and clinical practice with deciduous tooth pulp stem cells. In 2021, I launched Solaria Clinic Tokyo as a platform for further research and practice in stem cell therapy (currently submitting a plan for regenerative medicine as of May 2021) and cancer treatment targeting NKT cells.

Research on stem cells and culture supernatants still has many unexplored areas, and there are various difficulties in designing research and implementing it clinically. However, I believe there are no shortcuts, and I am committed to conducting grounded research and practice to deliver the benefits of regenerative medicine to as many people as possible.

I firmly believe that our efforts in regenerative medicine and cancer treatment will contribute to the advancement of medical choices, even in the face of emerging and ongoing challenges such as the COVID-19 pandemic.

Career Summary

1989: Graduated from University of Occupational and Environmental Health, Japan

1989: Joined Tokyo Women’s Medical University, Department of Nephrology

1995: Assistant at Tokyo Women’s Medical University, Department of Urology

1996: Studied transplant medicine in Cleveland Clinic, Ohio, USA

1999: Assistant at Tokyo Women’s Medical University, Department of Urology

2003: Lecturer at Tokyo Medical University, Department of Urology

2009: Joined Edogawa Hospital as Chief of Department of Urology, Director of Dialysis Center, and    Director of Transplant Regenerative Medicine Center (current position)

2017: Special Advisor at Solaria Clinic (current position)

2017: CEO of Panagea Inc. (current position)

2020: CEO of DEXON Pharmaceuticals Inc. (current position)

2021: Vice President of Edogawa Hospital (current position)

Certifications

  • Doctor of Medicine
  • Certified Regenerative Medicine Physician by the Japan Society for Regenerative Medicine
  • Councilor of the Japan Society of Anti-Aging Medicine
  • Specialist in Transplant Medicine certified by the Japan Society for Transplantation
  • Proctor for Urological Robotic-Assisted Surgery certified by the Japan Society of Endourology
  • Specialist and Instructor certified by the Japanese Urological Association
  • Specialist and Instructor certified by the Japanese Society for Dialysis Therapy

Affiliated Societies

  • Japan Society for Regenerative Medicine (Certified Regenerative Medicine Physician)
  • Japanese Urological Association
  • Japan Society of Endourology
  • Japanese Society for Dialysis Therapy
  • Japan Society for Transplantation
  • Japan Society for Peritoneal Dialysis
  • Japan Society for Cancer Therapy
  • Japan Society of Anti-Aging Medicine

Specialties

  • Regenerative Medicine

    Urologic Malignancies, Dialysis, Renal Transplantation